我武生物：控股股东拟减持0.86%股份

Group 1 - The controlling shareholder, WoW Consulting, plans to reduce its stake in WoW Bio (300357) by up to 4.5 million shares through block trading, representing 0.86% of the total share capital [1] - The actual controller, Hu Gengxi, will be the buyer of the shares being sold [1] - The company's director and deputy general manager, Zhang Lu, intends to reduce his holdings by up to 300,000 shares through centralized bidding, accounting for 0.06% of the total share capital [1] Group 2 - The reasons for the share reductions are stated as funding needs [1]